D. E. Shaw & Co. Inc. Sells 78,671 Shares of Owens & Minor, Inc. (NYSE:OMI)

D. E. Shaw & Co. Inc. decreased its holdings in Owens & Minor, Inc. (NYSE:OMI) by 10.6% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 663,718 shares of the company’s stock after selling 78,671 shares during the quarter. D. E. Shaw & Co. Inc. owned 0.86% of Owens & Minor worth $8,675,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Waldron Private Wealth LLC bought a new stake in shares of Owens & Minor in the fourth quarter worth approximately $406,000. JPMorgan Chase & Co. boosted its holdings in Owens & Minor by 68.4% in the third quarter. JPMorgan Chase & Co. now owns 376,830 shares of the company’s stock worth $5,912,000 after purchasing an additional 152,999 shares during the last quarter. Advisors Preferred LLC grew its position in Owens & Minor by 173.9% in the 4th quarter. Advisors Preferred LLC now owns 84,305 shares of the company’s stock worth $1,083,000 after purchasing an additional 53,529 shares during the period. Tower Research Capital LLC TRC raised its stake in Owens & Minor by 11.6% during the 4th quarter. Tower Research Capital LLC TRC now owns 20,259 shares of the company’s stock valued at $265,000 after buying an additional 2,112 shares during the last quarter. Finally, Barclays PLC raised its stake in Owens & Minor by 354.8% during the 3rd quarter. Barclays PLC now owns 133,702 shares of the company’s stock valued at $2,099,000 after buying an additional 104,305 shares during the last quarter. Institutional investors own 98.04% of the company’s stock.

Owens & Minor Stock Performance

Shares of OMI opened at $7.06 on Thursday. The business has a 50-day simple moving average of $7.96 and a two-hundred day simple moving average of $10.68. The company has a quick ratio of 0.45, a current ratio of 1.09 and a debt-to-equity ratio of 2.11. Owens & Minor, Inc. has a 52 week low of $6.07 and a 52 week high of $21.02. The stock has a market cap of $545.42 million, a price-to-earnings ratio of -10.86, a PEG ratio of 0.20 and a beta of 1.38.

Owens & Minor (NYSE:OMI) last announced its quarterly earnings data on Saturday, May 10th. The company reported $0.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.20 by $0.03. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. During the same quarter in the prior year, the firm posted $0.19 earnings per share. The company’s quarterly revenue was up .7% on a year-over-year basis. On average, analysts expect that Owens & Minor, Inc. will post 1.51 EPS for the current year.

Owens & Minor announced that its Board of Directors has initiated a stock repurchase plan on Friday, February 28th that allows the company to buyback $100.00 million in outstanding shares. This buyback authorization allows the company to reacquire up to 13.6% of its shares through open market purchases. Shares buyback plans are often a sign that the company’s management believes its shares are undervalued.

Insiders Place Their Bets

In other Owens & Minor news, major shareholder Coliseum Capital Management, L acquired 225,000 shares of the stock in a transaction dated Wednesday, April 9th. The shares were acquired at an average cost of $7.39 per share, for a total transaction of $1,662,750.00. Following the completion of the transaction, the insider now directly owns 11,482,955 shares of the company’s stock, valued at approximately $84,859,037.45. The trade was a 2.00% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Insiders bought a total of 2,718,412 shares of company stock worth $24,495,308 over the last three months. 3.69% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

OMI has been the subject of several research analyst reports. Citigroup cut their price objective on Owens & Minor from $13.00 to $11.00 and set a “buy” rating for the company in a report on Thursday, April 17th. JPMorgan Chase & Co. cut their price target on Owens & Minor from $14.00 to $10.00 and set an “underweight” rating for the company in a research note on Monday, March 10th. Robert W. Baird upped their price target on shares of Owens & Minor from $10.00 to $11.00 and gave the company a “neutral” rating in a research report on Monday, March 3rd. Finally, UBS Group dropped their price objective on shares of Owens & Minor from $25.00 to $13.00 and set a “buy” rating on the stock in a report on Thursday, February 13th. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, Owens & Minor presently has an average rating of “Hold” and an average price target of $12.50.

Owens & Minor Company Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.